CAPTRUST Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $822K | Sell |
|
|||||
|
2025
Q1 | $1.38M | Buy |
|
|||||
|
2024
Q4 | $1.19M | Sell |
|
|||||
|
2024
Q3 | $1.65M | Sell |
|
|||||
|
2024
Q2 | $1.93M | Buy |
|
|||||
|
2024
Q1 | $2.31M | Sell |
|
|||||
|
2023
Q4 | $2.59M | Buy |
|
|||||
|
2023
Q3 | $1.8M | Buy |
|
|||||
|
2023
Q2 | $829K | Sell |
|
|||||
|
2023
Q1 | $941K | Sell |
|
|||||
|
2022
Q4 | $1.07M | Buy |
|
|||||
|
2022
Q3 | $738K | Buy |
|
|||||
|
2022
Q2 | $743K | Buy |
|
|||||
|
2022
Q1 | $837K | Buy |
|
|||||
|
2021
Q4 | $1.07M | Sell |
|
|||||
|
2021
Q3 | $1.36M | Buy |
|
|||||
|
2021
Q2 | $1.19M | Sell |
|
|||||
|
2021
Q1 | $1.01M | Buy |
|
|||||
|
2020
Q4 | $446K | Sell |
|
|||||
|
2020
Q3 | $575K | Sell |
|
|||||
|
2020
Q2 | $443K | Buy |
|
|||||
|
2020
Q1 | $299K | Sell |
|
|||||
|
2019
Q4 | $406K | Buy |
|
|||||
|
2019
Q3 | $75K | Sell |
|
|||||
|
2019
Q2 | $82K | Sell |
|
|||||
|
2019
Q1 | $85K | Sell |
|
|||||
|
2018
Q4 | $69K | Buy |
|
|||||
|
2018
Q3 | $41K | Sell |
|
|||||
|
2018
Q2 | $44K | Sell |
|
|||||
|
2018
Q1 | $41K | Buy |
|
|||||
|
2017
Q4 | $23K | Buy |
|